About 200 reports

Global Sepsis Diagnostics Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## Technology Analysis ##. ## Application Analysis ##. ## End User Anal

  • Blood Disease
  • Diagnostics
  • United States
  • Forecast
  • Market Size
  • 2.2.5 Laboratory Tests for Pulmonary Embolism

It can also show other pathologies and lung defects.

  • Blood Disease
  • Cardiovascular Disease
  • World
  • Cyclopharm Limited
  • Lifesciences Limited

Oral Mucositis: understanding the pathology and management.

  • Blood Disease
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.

Laboratories performing genetic tests can be accredited through the Clinical Pathology Accreditation UK Ltd scheme.

  • Blood Disease
  • North America
  • United States
  • World
  • Forecast
  • 7.2.2 Pipeline Programs Targeting Hepcidin

Indeed, previous pathology studies have revealed that iron disorders are due to the dysregulation of the hepcidin-ferroportin axis.

  • Blood Disease
  • World
  • Acceleron Pharma, Inc.
  • La Jolla Pharmaceutical Company
  • Omeros Corporation

EACH PARTY, THROUGH ITS REPRESENTATIVES, SHALL HAVE ONE (##) VOTE ON THE JSC AND EACH SUBCOMMITTEE.

  • Blood Disease
  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC

As of a 2017 report published in the Journal of Genetic Counselling, the counts are very low, including ##: ##, ##, ## in Indonesia, ##: ##, ##, ## in Hong Kong, ##: ##, ##, ## in Singapore, ##:##, ## in Taiwan, ##: ##, ##, ## in Vietnam, ##: ##, ##,

  • Blood Disease
  • 23andMe, Inc.
  • Cepheid
  • Illumina, Inc.
  • Sequenom, Inc.
  • 9 Appendix

Molecular Pathology; ##(##): ##-## Brand B, et al. (2015).

  • Blood Disease
  • World
  • CSL Behring GmbH
  • Novo Nordisk Group
  • Pfizer Inc.

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • Biogen Idec Inc.
  • CSL Behring GmbH

Anti-PD-## and anti-PDL-## antibodies are novel drugs used in certain cancers to overcome the immunosuppressive effects of PD-##/ PDL-## signaling in anti-tumor T cells.

  • Blood Disease
  • Gilead Sciences, Inc.
  • Incyte Corporation
  • Novartis AG
  • Promedior, Inc.
  • FEB 14, 2018: FEINSTEIN INSTITUTE RESEARCHER RECEIVES $3.6M IN GRANTS TO STUDY RARE BLEEDING CONDITION

The DOD has placed a research focus on vascular pathologies, like HHT, that might affect military personnel.

  • Blood Disease
  • Pharmaceutical
  • Therapy
  • United States
  • Social Conditions

The clinical course of these pathologies and treatment outcomes vary between the affected individuals.

  • Blood Disease
  • Pathology

Blood; ##(##): ##-##.

  • Blood Disease
  • Baxalta Incorporated
  • Biogen Idec Inc.
  • CSL Behring GmbH
  • Novo Nordisk Group
  • 9.2.5 BMS-936559
  • 4.1.1 ETIOLOGY

DIAGNOSTIC PATHOLOGY; ##(##): ##.

  • Blood Disease
  • Demand
  • Faron Pharmaceuticals Ltd
  • Ferring International Center S.A.
  • Shionogi & Co., Ltd.

DISEASES OF AQUATIC ORGANISMS ##, ##, ##-##.

  • Aquaculture
  • Blood Disease
  • World
  • Supply
  • Zoetis Inc.

Heather holds a Bachelor' s degree in Molecular and Cell Biology from the University of Connecticut, and a PhD in Pathology and Cell and Molecular Biology from Boston University School of Medicine.

  • Blood Disease
  • United States
  • Amgen Inc.
  • BeyondSpring Pharmaceuticals Inc.
  • Helsinn Group
  • 9 Appendix

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group

American Journal of Clinical Pathology; ##(##): ##-##.

  • Blood Disease
  • Japan
  • United States
  • Eisai Co., Ltd.
  • Rigel Pharmaceuticals, Inc.
  • REFERENCES

Modern Pathology. 2012; ##():##- ## ##.

  • Blood Disease

Hemophilia

4546 5000 3864
  • STRENGTHS AND LIMITATIONS

Hemophilia Disease Coverage | Treatment: Hemophilia DMKC## Advate ## ## ## ## ## ## ## ## Kogenate/ Helixate ## ## ## ## ## ## ## ## Xyntha/ ReFacto ## ## ## ## ## ## ## ## Recombinate ## ## ## ## ## ## ## ## Humate P ## ## ## ## ## ## ## ## Beriate P/ N ## ## ## ## ##

  • Blood Disease
  • European Union
  • Japan
  • North America
  • United States
  • SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES,
  • KEY FINDINGS

The sepsis diagnostics market projected to grow at a CAGR of 9.1%. The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections,...

  • Blood Disease
  • North America
  • United States
  • Market Size
  • Roche Group

BLOOD; ##(##): ##-##.

  • Blood Disease
  • World
  • Demand
  • Baxalta Incorporated
  • Novo Nordisk Group
  • 9 Appendix

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group
  • 9 Appendix

BLOOD; ##(##): ##-##.

  • Blood Disease
  • Demand
  • Baxalta Incorporated
  • CSL Behring GmbH
  • Novo Nordisk Group

Alsobrook II, DABCC, FACB, Laboratory Site Director and Vice President of Operations for Clinical Genomics Pathology.

  • Blood Disease
  • Diagnostics
  • United States
  • Company
  • Quest Diagnostics Incorporated
  • Jun 02, 2016: Study Published in the American Journal of Clinical Pathology Demonstrates T2Candida Panel Provides Rapid and Accurate Diagnosis of Candida, a Leading Cause of Sepsis, in Pediatric Patients

Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument...

  • Biosystem
  • Blood Disease
  • United States
  • Company
  • T2 Biosystems, Inc.

In one of the largest studies ever conducted to directly compare the use of digital pathology to optical microscopes, ## pathologists at four clinical study sites - Cleveland Clinic, University of Virginia, Miraca Life Sciences and Advanced Pathology Associates conducted a

  • Blood Disease
  • Drug Discovery And Development
  • Patient Data Management
  • United States
  • GlobalData's company

THE AMERICAN JOURNAL OF PATHOLOGY; ##(##): ##-##.

  • Blood Disease
  • United States
  • Altor BioScience Corporation
  • Ferring International Center S.A.
  • InflaRx GmbH
  • Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Product Development Milestones

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Blood Disease
  • United States
  • World
  • Product Initiative
  • Acceleron Pharma, Inc.
  • LYMPHATIC FILARIASIS (MULTIVALENT) VACCINE - DRUG PROFILE

The molecules developed by Companies in Phase II and Preclinical stages are ## and ## respectively.

  • Blood Disease
  • United States
  • World
  • Product Initiative
  • AbbVie Inc.